Pharmacogenetic Aspects of Neuroleptic Malignant Syndrome

Publisher： Bentham Science Publishers

E-ISSN： 1875-6204|4|2|113-119

ISSN： 1570-1603

Source： Current Pharmacogenomics, Vol.4, Iss.2, 2006-01, pp. : 113-119

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antidepressants and neuroleptic malignant syndrome

By Assion H.J.   Heinemann F.   Laux G.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 293-293

Elsevier

Access to resources Recommend Favorite

Identification and Treatment of Neuroleptic Malignant Syndrome

By  

Child and Adolescent Psychopharmacology News, Vol. 6, Iss. 3, 2001-06 ,pp. : 1-6

Guilford Publications Inc

Access to resources Recommend Favorite

Mild neuroleptic malignant syndrome: problems of differential diagnosis

By Belelli G.   Pezzoli A.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 345-345

Elsevier

Access to resources Recommend Favorite

Aripiprazole: Neuroleptic malignant syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1124, 2006-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Paliperidone: Neuroleptic malignant syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1185, 2008-01 ,pp. : 24-25

Adis International

Access to resources Recommend Favorite